TEL AVIV, Jan 8 (Reuters) - The new chief executive of Teva Pharmaceutical Industries will have to go beyond cost cutting and lay-offs to fend off cut-throat competition and nurse the drug company back to health.

from Reuters: Company News http://feeds.reuters.com/~r/reuters/companyNews/~3/33Sa7WUR-gQ/story01.htm
via IFTTT
from Reuters: Company News http://feeds.reuters.com/~r/reuters/companyNews/~3/33Sa7WUR-gQ/story01.htm
via IFTTT
No hay comentarios:
Publicar un comentario